China (Mainland)
Assessedsupplier 
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl],cyclic (3?5)-disulfide CAS NO.128517-07-7
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T,MoneyGram,Other
- Product Details
Keywords
- Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl],cyclic (3?5)-disulfide price
- Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl],cyclic (3?5)-disulfide CAS 128517-07-7
- Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl],cyclic (3?5)-disulfide supplier in China
Quick Details
- ProName: Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-...
- CasNo: 128517-07-7
- Molecular Formula: C24H36N4O6S2
- Appearance: white powder
- Application: Labelled Romidepsin (R425060). Romidep...
- DeliveryTime: Within 15 working days
- PackAge: 100g/bottle,1kg/bottle,25kg/drum or as...
- Port: Shanghai, Ningbo, Tianjin, etc
- ProductionCapacity: 1 Kilogram/Day
- Purity: 99%
- Storage: Stored in cool, dry and ventilation pl...
- Transportation: by courier door to door or by sea
- LimitNum: 1 Gram
Superiority
Superior quality, moderate price & quick delivery.
Details
| (1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone Chemical Properties |
| mp | 219-224°C |
| density | 1.174 |
| storage temp. | Amber Vial, -20°C Freezer, Under Inert Atmosphere |
| Safety Information |
| (1S,4Z,7S,10S,11E,20R)-4-ethylidene-7,20-dipropan-2-yl-9-oxa-15,16-dit hia-3,6,18,21-tetrazabicyclo[8.7.6]tricos-11-ene-2,5,8,19,22-pentone Usage And Synthesis |
| Chemical Properties | Pale Yellow Solid |
| Usage | Labelled Romidepsin (R425060). Romidepsin is a histone deacetylase inhibitor that can alter chromatin structure and gene transcription leading to multiple changes in cellular protein production. This may result in cell cycle arrest and tumor growth inhibition. Romidepsin has shown anti-proliferative activity in vitro against multiple mouse and human tumor cell lines and in vivo in human tumor xeno graft models. Romidepsin can be administered with a second agent, such as a cytotoxic agent, a steroidal agent, a proteasome inhibitor, or a kinase inhibitor. |